BBC vs VXUS
Virtus LifeSci Biotech Clinical Trials ETF vs Vanguard Total International Stock ETF
Quick Verdict
VXUS has a lower expense ratio. BBC delivered stronger 1-year returns. VXUS offers more diversification with 7861 holdings.
Side-by-Side Comparison
| Metric | BBC | VXUS | Winner |
|---|---|---|---|
| Expense Ratio | 0.65% | 0.05% | |
| AUM | $47M | $156.5B | |
| Dividend Yield | 1.24% | 2.60% | |
| Holdings | 123 | 8,747 | |
| YTD Return | +39.56% | +14.57% | |
| 1Y Return | +154.07% | +27.82% | |
| 3Y Return (annualized) | +34.90% | +19.27% | |
| 5Y Return (annualized) | +3.34% | +9.28% | |
| Volatility (annualized) | 35.9% | 15.1% | |
| Max Drawdown | -76.8% | -39.9% | |
| Fund Family | Virtus Investment Partners | Vanguard (US) | |
| Category | Equity | Equity | |
| Inception | Dec 16, 2014 | Jan 26, 2011 |
BBC vs VXUS Performance
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a ETF from Virtus Investment Partners and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US). Over the past year BBC returned +154.07% while VXUS returned +27.82%. Year to date, BBC is up 39.56% versus a gain of 14.57% for VXUS.
Over three years, BBC compounded at +34.90% per year against +19.27% for VXUS; over five years the annualized figures are +3.34% and +9.28% respectively. Across the full 12-year window we track, BBC has the edge at +6.51% annualized vs +4.86%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
BBC has been the more volatile fund, with annualized monthly volatility of 35.9% compared with 15.1% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -76.8% for BBC and -39.9% for VXUS. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.47. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
BBC charges 0.65% per year while VXUS charges 0.05%. On a $10,000 position that is $65 vs $5 annually, a gap of $60 per year that compounds over a long holding period. On income, BBC currently yields 1.24% against 2.60% for VXUS.
Holdings Overlap
BBC and VXUS share 0 holdings out of 7982 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, BBC or VXUS?
BBC has an expense ratio of 0.65% while VXUS charges 0.05%. VXUS is the cheaper option. On a $10,000 investment, that is $60 per year of difference.
Which performed better, BBC or VXUS?
Over the past year BBC returned +154.07% vs +27.82% for VXUS, so BBC leads on 1-year performance. Over the longest common window we track (12 years), BBC annualized +6.51% vs +4.86% for VXUS. Past performance does not guarantee future results.
Which is riskier, BBC or VXUS?
BBC has been the more volatile fund at 35.9% annualized versus 15.1% for VXUS. Worst drawdown: BBC -76.8% vs VXUS -39.9%.
Should I hold both BBC and VXUS?
BBC and VXUS have a monthly-return correlation of 0.47, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between BBC and VXUS?
BBC and VXUS share 0 common holdings with a 0.0% weight overlap. Combined, they hold 7982 unique securities.
Which pays a higher dividend, BBC or VXUS?
BBC yields 1.24% while VXUS yields 2.60%, so VXUS currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.